Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
INR 159.12
(1.15%)
INR 159.12
(1.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 536.39 Million INR | 0.83% |
| 2022 | 488.9 Million INR | 28.55% |
| 2021 | -497.05 Million INR | -42.99% |
| 2020 | 684.33 Million INR | 20.05% |
| 2019 | 566.15 Million INR | 24.16% |
| 2018 | 434.38 Million INR | 6.6% |
| 2017 | 407.54 Million INR | 43.26% |
| 2016 | 289.72 Million INR | 17.72% |
| 2015 | 251.29 Million INR | -27.86% |
| 2014 | 350.7 Million INR | 2.87% |
| 2013 | 341.92 Million INR | 65.87% |
| 2012 | 203.48 Million INR | 11.87% |
| 2011 | 169.02 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 365.35 Million INR | 745.09% |
| 2024 Q2 | 48.88 Million INR | -86.67% |
| 2023 Q1 | 369.25 Million INR | 750.01% |
| 2023 FY | - INR | 0.83% |
| 2023 Q3 | 56.82 Million INR | 1.93% |
| 2023 Q2 | 55.75 Million INR | -84.9% |
| 2023 Q4 | 39.28 Million INR | -30.88% |
| 2022 Q4 | 43.44 Million INR | -23.43% |
| 2022 Q2 | 49.53 Million INR | -85.63% |
| 2022 FY | - INR | 28.55% |
| 2022 Q1 | 344.8 Million INR | 263.02% |
| 2022 Q3 | 56.73 Million INR | 14.53% |
| 2021 Q1 | 485.3 Million INR | 379.43% |
| 2021 Q4 | -211.51 Million INR | -436.32% |
| 2021 FY | - INR | -42.99% |
| 2021 Q3 | 62.89 Million INR | 31.03% |
| 2021 Q2 | 47.99 Million INR | -90.11% |
| 2020 FY | - INR | 20.05% |
| 2020 Q4 | 101.22 Million INR | 38.45% |
| 2020 Q1 | 441.94 Million INR | 538.95% |
| 2020 Q2 | 58.5 Million INR | -86.76% |
| 2020 Q3 | 73.11 Million INR | 24.97% |
| 2019 Q4 | 69.16 Million INR | 13.83% |
| 2019 Q3 | 60.76 Million INR | 7.21% |
| 2019 FY | - INR | 24.16% |
| 2019 Q1 | 375.45 Million INR | 655.39% |
| 2019 Q2 | 56.67 Million INR | -84.9% |
| 2018 Q3 | 63.59 Million INR | 6.72% |
| 2018 Q4 | 49.7 Million INR | -21.85% |
| 2018 FY | - INR | 6.6% |
| 2018 Q1 | 279.79 Million INR | 529.62% |
| 2018 Q2 | 59.59 Million INR | -78.7% |
| 2017 Q4 | 44.43 Million INR | -35.82% |
| 2017 FY | - INR | 43.26% |
| 2017 Q1 | 234.21 Million INR | 2094.62% |
| 2017 Q2 | 65.25 Million INR | -72.14% |
| 2017 Q3 | 69.23 Million INR | 6.1% |
| 2016 Q1 | 198.37 Million INR | 993.75% |
| 2016 Q3 | 52.99 Million INR | 60.33% |
| 2016 Q4 | 10.67 Million INR | -79.86% |
| 2016 Q2 | 33.05 Million INR | -83.34% |
| 2016 FY | - INR | 17.72% |
| 2015 Q3 | 38.45 Million INR | 219.41% |
| 2015 Q4 | -22.19 Million INR | -157.71% |
| 2015 Q2 | -32.2 Million INR | -112.0% |
| 2015 Q1 | 268.36 Million INR | 637.47% |
| 2015 FY | - INR | -27.86% |
| 2014 FY | - INR | 2.87% |
| 2014 Q4 | -49.92 Million INR | -197.46% |
| 2014 Q3 | 51.23 Million INR | 29.8% |
| 2014 Q2 | 39.46 Million INR | -88.49% |
| 2014 Q1 | 342.89 Million INR | 3212.64% |
| 2013 Q4 | -11.01 Million INR | -117.93% |
| 2013 FY | - INR | 65.87% |
| 2013 Q1 | 248.47 Million INR | 1873.68% |
| 2013 Q2 | 40.4 Million INR | -83.74% |
| 2013 Q3 | 61.42 Million INR | 52.03% |
| 2012 Q1 | 281.93 Million INR | 0.0% |
| 2012 Q3 | 49.34 Million INR | 60.83% |
| 2012 Q4 | 12.58 Million INR | -74.49% |
| 2012 Q2 | 30.68 Million INR | -89.12% |
| 2012 FY | - INR | 11.87% |
| 2011 FY | - INR | 0.0% |